This post was contributed by a community member. The views expressed here are the author's own.
Called Zephyr valves, the devices were approved in 2018 under the FDA’s breakthrough device status because of the need for new treatment options for patients with Chronic Obstructive Pulmonary Disease (COPD), the third leading cause of death worldwide. COPD can vary in severity, but for people with advanced disease every activity can leave them breathless.
The valves are the first less-invasive option for patients with one form of COPD: severe emphysema. These patients had few options before this treatment and often were waiting on lung transplant lists or oxygen-dependent with very poor quality of life.
Find out what's happening in Norwichwith free, real-time updates from Patch.
The views expressed in this post are the author's own. Want to post on Patch?
The rules of replying:
- Be respectful. This is a space for friendly local discussions. No racist, discriminatory, vulgar or threatening language will be tolerated.
- Be transparent. Use your real name, and back up your claims.
- Keep it local and relevant. Make sure your replies stay on topic.
- Review the Patch Community Guidelines.